The Pharmacological Activity of Epigallocatechin-3-Gallate (EGCG) on Alzheimer's Disease Animal Model: A Systematic Review

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement

PRISMA-P Group, Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., & Stewart, L. A. (2015) · Systematic Reviews · doi:10.1186/2046-4053-4-1 · Cited by 26,223 · see citing works

The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics

Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864 · see citing works

Alzheimer's Disease: Genes, Proteins, and Therapy

Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063 · see citing works

2016 Alzheimer's disease facts and figures

Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069 · see citing works

Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease

Zhang, B., Gaiteri, C., Bodea, L.-G., Wang, Z., McElwee, J., Podtelezhnikov, A. A., Zhang, C., Xie, T., Tran, L., Dobrin, R., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.030 · Cited by 1,657 · see citing works

2015 Alzheimer's disease facts and figures

Alzheimer's Association (2015) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.02.003 · Cited by 1,641 · see citing works

The many faces of tau

Morris, M., Maeda, S., Vossel, K., & Mucke, L. (2011) · Neuron · doi:10.1016/j.neuron.2011.04.009 · Cited by 899 · see citing works

Chemoprevention of Human Prostate Cancer by Oral Administration of Green Tea Catechins in Volunteers with High-Grade Prostate Intraepithelial Neoplasia: A Preliminary Report from a One-Year Proof-of-Principle Study

Bettuzzi, S., Brausi, M. A., Rizzi, F., Castagnetti, G., Peracchia, G., & Corti, A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1145 · Cited by 817 · see citing works

Green tea and its polyphenolic catechins: Medicinal uses in cancer and noncancer applications

Zaveri, N. T. (2006) · Life Sciences · doi:10.1016/j.lfs.2005.12.006 · Cited by 811 · see citing works

P1‐146: Chlamydia Pneumoniae‐Infected Astrocytes Alter Their Expression of Adam10, Bace1, and Presenilin‐1 Proteases

Al-Atrache, Z., Cader, A., & Appelt, D. M. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.06.894 · Cited by 765 · see citing works

Green tea Epigallocatechin-3-Gallate (EGCG) Modulates Amyloid Precursor Protein Cleavage and Reduces Cerebral Amyloidosis in Alzheimer Transgenic Mice

Rezai-Zadeh, K., Shytle, D., Sun, N., Mori, T., Hou, H., Jeanniton, D., Ehrhart, J., Townsend, K., Zeng, J., Morgan, D., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1521-05.2005 · Cited by 713 · see citing works

Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals.

Chow, H.-H. S., Cai, Y., Hakim, I. A., Crowell, J. A., Shahi, F., Brooks, C. A., Dorr, R. T., Hara, Y., & Alberts, D. S. (2003) · PubMed · Cited by 699 · see citing works

DT‐01‐04: The efficacy of RVT‐101, a 5‐ht6 receptor antagonist, as an adjunct to donepezil in adults with mild‐to‐moderate Alzheimer's disease: Completer analysis of a phase 2b study

Lombardo, I., Ramaswamy, G., Piscitelli, S. C., & Friedhoff, L. T. (2015) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.08.154 · Cited by 656 · see citing works

Green tea polyphenol (–)‐epigallocatechin‐3‐gallate prevents N ‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced dopaminergic neurodegeneration

Levites, Y., Weinreb, O., Maor, G., Youdim, M. B. H., & Mandel, S. A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00490.x · Cited by 567 · see citing works

The activities of amyloids from a structural perspective

Riek, R., & Eisenberg, D. S. (2016) · Nature · doi:10.1038/nature20416 · Cited by 504 · see citing works

Oxidative stress in Alzheimer disease: A possibility for prevention

Bonda, D., Wang, X., Perry, G. L., Nunomura, A., Tabaton, M., Zhu, X., & Smith, M. A. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.04.005 · Cited by 481 · see citing works

Green tea epigallocatechin-3-gallate (EGCG) reduces β-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice

Rezai-Zadeh, K., Arendash, G. W., Hou, H., Fernandez, F., Jensen, M., Runfeldt, M., Shytle, R. D., & Tan, J. (2008) · Brain Research · doi:10.1016/j.brainres.2008.02.107 · Cited by 459 · see citing works

The contribution of neuroinflammation to amyloid toxicity in Alzheimer's disease

Minter, M. R., Taylor, J. M., & Crack, P. J. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13411 · Cited by 451 · see citing works

Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E.

Chow, H. ‐. S., Cai, Y., Alberts, D. S., Hakim, I. A., Dorr, R. T., Shahi, F., Crowell, J. A., Yang, C. S., & Hara, Y. (2001) · PubMed · Cited by 419 · see citing works

GSK-3 is essential in the pathogenesis of Alzheimer's disease

Takashima, A. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9s335 · Cited by 395 · see citing works

Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model

Cano, A., Ettcheto, M., Chang, J.-H., Barroso, E., Espina, M., Kühne, B. A., Barenys, M., Auladell, C., Folch, J., Souto, E. B., et al. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.03.010 · Cited by 337 · see citing works

Good Laboratory Practice: Preventing Introduction of Bias at the Bench

Macleod, M. R., Fisher, M., O'Collins, V., Sena, E. S., Dirnagl, U., Bath, P. M. W., Buchan, A., van der Worp, H. B., Traystman, R., Minematsu, K., et al. (2009) · Stroke · doi:10.1161/strokeaha.108.525386 · Cited by 331 · see citing works

Early-onset versus late-onset Alzheimer's disease: the case of the missing APOE ɛ4 allele

van der Flier, W. M., Pijnenburg, Y. A. L., Fox, N. C., & Scheltens, P. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70306-9 · Cited by 306 · see citing works

Role of the nicotinic acetylcholine receptor in Alzheimer's disease pathology and treatment

Lombardo, S., & Maskos, U. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.11.018 · Cited by 303 · see citing works

Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial

de la Torre, R., de Sola, S., Hernández, G., Farré, M., Pujol, J., Rodríguez, J. C., Espadaler, J. M., Langohr, K., Cuenca‐Royo, A., Príncipe, A., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30034-5 · Cited by 291 · see citing works

Epigallocatechin‐3‐gallate, a DYRK1A inhibitor, rescues cognitive deficits in D own syndrome mouse models and in humans

de la Torre, R., Sola, S. D., Pons‐Espinal, M., Duchon, A., de Lagrán, M. M., Farré, M., Fitó, M., Benejam, B., Langohr, K., Rodríguez, J. C., et al. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300325 · Cited by 283 · see citing works

Nanolipidic particles improve the bioavailability and α-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer's disease

Smith, A., Giunta, B., Bickford, P. C., Fountain, M., Tan, J., & Shytle, R. D. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.01.012 · Cited by 280 · see citing works

Green Tea (-)-Epigallocatechin-3-Gallate Inhibits β-Amyloid-Induced Cognitive Dysfunction through Modification of Secretase Activity via Inhibition of ERK and NF-κB Pathways in Mice ,

Lee, J. W., Lee, Y. K., Ban, J. O., Ha, T. Y., Yun, Y. P., Han, S., Oh, K. W., & Hong, J. T. (2009) · Journal of Nutrition · doi:10.3945/jn.109.109785 · Cited by 269 · see citing works

Tea Polyphenols Decrease Serum Levels of Prostate-Specific Antigen, Hepatocyte Growth Factor, and Vascular Endothelial Growth Factor in Prostate Cancer Patients and Inhibit Production of Hepatocyte Growth Factor and Vascular Endothelial Growth Factor In vitro

McLarty, J. W., Bigelow, R. L. H., Smith, M., et al. (2009) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0167 · Cited by 236 · see citing works

Animal models in the drug discovery pipeline for Alzheimer's disease

Dam, D. V., & Deyn, P. P. D. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01299.x · Cited by 228 · see citing works

β-Amyloid-(1–42) Impairs Activity-dependent cAMP-response Element-binding Protein Signaling in Neurons at Concentrations in Which Cell Survival Is Not Compromised

Tong, L., Thornton, P. L., Balazs, R., & Cotman, C. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010450200 · Cited by 206 · see citing works

Changes in Amyloid-β and Tau in the Cerebrospinal Fluid of Transgenic Mice Overexpressing Amyloid Precursor Protein

Maia, L. F., Kaeser, S. A., Reichwald, J., Hruscha, M., Martus, P., Staufenbiel, M., & Jucker, M. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006446 · Cited by 204 · see citing works

Epigallocatechin-3-gallate (EGCG)-Stabilized Selenium Nanoparticles Coated with Tet-1 Peptide To Reduce Amyloid-β Aggregation and Cytotoxicity

Zhang, J., Zhou, X., Yu, Q., Yang, L., Sun, D., Zhou, Y., & Liu, J. (2014) · ACS Applied Materials & Interfaces · doi:10.1021/am501341u · Cited by 199 · see citing works

Epigallocatechin-3-gallate prevents systemic inflammation-induced memory deficiency and amyloidogenesis via its anti-neuroinflammatory properties

Lee, Y., Choi, D., Yun, Y., Han, S., Oh, K., & Hong, J. T. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2012.06.011 · Cited by 195 · see citing works

EGCG Nanoparticles Attenuate Aluminum Chloride Induced Neurobehavioral Deficits, Beta Amyloid and Tau Pathology in a Rat Model of Alzheimer’s Disease

Singh, N., Bhardwaj, V., Ravi, C., Ramesh, N., Mandal, A., & Khan, Z. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00244 · Cited by 186 · see citing works

(−)-Epigallocatechin-3-gallate prevents lipopolysaccharide-induced elevation of beta-amyloid generation and memory deficiency

Lee, Y. K., Yuk, D. Y., Lee, J. W., Lee, S. Y., Ha, T. Y., Oh, K. W., Yun, Y. P., & Hong, J. T. (2008) · Brain Research · doi:10.1016/j.brainres.2008.10.012 · Cited by 181 · see citing works

Green tea (−)epigallocatechin-3-gallate reverses oxidative stress and reduces acetylcholinesterase activity in a streptozotocin-induced model of dementia

Biasibetti, R., Tramontina, A. C., Costa, A. P., Dutra, M. F., Quincozes‐Santos, A., Nardin, P., Bernardi, C. L., Wartchow, K. M., Lunardi, P. S., & Gonçalves, C. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.08.039 · Cited by 177 · see citing works

Phase 2 trial of daily, oral polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic leukemia

Shanafelt, T. D., Call, T. G., Zent, C. S., Leis, J. F., LaPlant, B. R., Bowen, D. A., Roos, M., Laumann, K. M., Ghosh, A. K., Lesnick, C. E., et al. (2012) · Cancer · doi:10.1002/cncr.27719 · Cited by 170 · see citing works

Green tea extract decreases muscle necrosis in mdx mice and protects against reactive oxygen species

Buetler, T. M., Renard, M., Offord, E., Schneider, H., & Rüegg, U. T. (2002) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/75.4.749 · Cited by 148 · see citing works

Beneficial Effects of Dietary EGCG and Voluntary Exercise on Behavior in an Alzheimer's Disease Mouse Model

Walker, J. M., Klakotskaia, D., Ajit, D., Weisman, G. A., Wood, W. G., Sun, G. Y., Serfözö, P. D., Simonyi, Á., & Schachtman, T. R. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-140981 · Cited by 128 · see citing works

(−)-Epigallocatechin-3-gallate attenuates cognitive deterioration in Alzheimer׳s disease model mice by upregulating neprilysin expression

Chang, X., Rong, C., Chen, Y., Yang, C., Hu, Q., Mo, Y., Zhang, C., Gu, X., Zhang, L., He, W.-Q., et al. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.04.004 · Cited by 119 · see citing works

(−)-Epigallocatechin-3-Gallate Ameliorates Learning and Memory Deficits by Adjusting the Balance of TrkA/p75NTR Signaling in APP/PS1 Transgenic Mice

Liu, M., Chen, F., Sha, L., Wang, S., Lin, T., Yao, L., He, M., Yao, Z., Liu, H., Zhu, Z., et al. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8608-2 · Cited by 117 · see citing works

Exposure and toxicity of green tea polyphenols in fasted and non-fasted dogs

Kapetanović, I. M., Crowell, J. A., Krishnaraj, R., Zakharov, A. D., Lindeblad, M. O., & Lyubimov, A. (2009) · Toxicology · doi:10.1016/j.tox.2009.03.007 · Cited by 111 · see citing works

A Pilot Study to Evaluate the Safety and Efficacy of an Oral Dose of (−)-Epigallocatechin-3-Gallate–Rich Polyphenon E in Patients With Mild to Moderate Ulcerative Colitis

Dryden, G. W., Lam, A. P., Beatty, K., et al. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e31828f5198 · Cited by 109 · see citing works

Novel epigallocatechin gallate (EGCG) analogs activate AMP-activated protein kinase pathway and target cancer stem cells

Chen, D., Pamu, S., Cui, Q. C., Chan, T. H., & Dou, Q. P. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.03.002 · Cited by 106 · see citing works

Phase IB Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Women with Hormone Receptor–Negative Breast Cancer

Crew, K. D., Brown, P. H., Greenlee, H., Bevers, T. B., Arun, B., Hudis, C. A., McArthur, H. L., Chang, J. C., Rimawi, M. F., Vornik, L. A., et al. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-12-0117 · Cited by 105 · see citing works

Neuroprotective Effects of (-)-Epigallocatechin-3-gallate on Aging Mice Induced by D-Galactose

He, M., Zhao, L., Wei, M.-J., et al. (2009) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.32.55 · Cited by 97 · see citing works

Epigallocatechin-3-gallate loaded PEGylated-PLGA nanoparticles: A new anti-seizure strategy for temporal lobe epilepsy

Cano, A. C., Ettcheto, M., Espina, M., Auladell, C., Calpena, A. C., Folch, J., Barenys, M., Sánchez‐López, E., Camins, A., & García, M. L. (2018) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2018.01.019 · Cited by 95 · see citing works

A practical algorithm for managing Alzheimer's disease: what, when, and why?

Cummings, J. L., Isaacson, R., Schmitt, F. A., & Velting, D. M. (2015) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.166 · Cited by 93 · see citing works

Effects of green tea extract on learning, memory, behavior and acetylcholinesterase activity in young and old male rats

Kaur, T., Pathak, C. M., Pandhi, P., & KHANDUJA, K. L. (2007) · Brain and Cognition · doi:10.1016/j.bandc.2007.10.003 · Cited by 90 · see citing works

Clinical aspects and biomarkers of Alzheimer's disease in Down syndrome

Zis, P., & Strydom, A. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.08.024 · Cited by 88 · see citing works

Epigallocatechin gallate (EGCG) suppresses β-amyloid-induced neurotoxicity through inhibiting c-Abl/FE65 nuclear translocation and GSK3β activation

Lin, C., Chen, T., Chiu, M., Way, T., & Lin, J. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.05.012 · Cited by 86 · see citing works

Results of a phase II randomized, double-blind, placebo-controlled trial of Polyphenon E in women with persistent high-risk HPV infection and low-grade cervical intraepithelial neoplasia

García, F., Cornelison, T. L., Nuño, T., et al. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2013.12.034 · Cited by 74 · see citing works

Polyphenon E, non-futile at neuroprotection in multiple sclerosis but unpredictably hepatotoxic: Phase I single group and phase II randomized placebo-controlled studies

Lovera, J. F., Ramos, A. B., Devier, D. J., Garrison, V., Kovner, B., Reza, T., Koop, D. R., Rooney, W. D., Foundas, A. L., & BOURDETTE, D. N. (2015) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2015.08.006 · Cited by 68 · see citing works

(−)-Epigallocatechin-3-gallate ameliorates memory impairment and rescues the abnormal synaptic protein levels in the frontal cortex and hippocampus in a mouse model of Alzheimer’s disease

Guo, Y., Zhao, Y., Nan, Y., Wang, X., Chen, Y., & Wang, S. (2017) · Neuroreport · doi:10.1097/wnr.0000000000000803 · Cited by 67 · see citing works

Epigallocatechin Gallate Reduces Amyloid β‐Induced Neurotoxicity via Inhibiting Endoplasmic Reticulum Stress‐Mediated Apoptosis

Du, K., Liu, M., Zhong, X., Yao, W., Xiao, Q., Wen, Q., Yang, B., & Wei, M. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201700890 · Cited by 60 · see citing works

The beneficial effect of (-)-epigallocatechin-3-gallate in an experimental model of Alzheimer's disease in rat: a behavioral analysis.

Rasoolijazi, H., Joghataie, M. T., Roghani, M., & Nobakht, M. (2007) · PubMed · Cited by 58 · see citing works

Physiological effects of epigallocatechin-3-gallate (EGCG) on energy expenditure for prospective fat oxidation in humans: A systematic review and meta-analysis

Kapoor, M. P., Sugita, M., Fukuzawa, Y., & Ōkubo, T. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.10.013 · Cited by 53 · see citing works

(−)-Epigallocatechin-3-gallate alleviates spatial memory impairment in APP/PS1 mice by restoring IRS-1 signaling defects in the hippocampus

Jia, N., Han, K. S., Kong, J., Zhang, X., Sha, S., Ren, G.-R., & Cao, Y. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1675-x · Cited by 50 · see citing works

Neuroprotective effects of baicalein in animal models of Parkinson's disease: A systematic review of experimental studies

Zhu, Q., Zhuang, X., & Lu, J. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.09.215 · Cited by 50 · see citing works

The Role of Insulin Resistance and Protein O-GlcNAcylation in Neurodegeneration

Ansari, S. A., & Emerald, B. S. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00473 · Cited by 35 · see citing works

Green Tea Catechin Extract Supplementation Does Not Influence Circulating Sex Hormones and Insulin-Like Growth Factor Axis Proteins in a Randomized Controlled Trial of Postmenopausal Women at High Risk of Breast Cancer

Samavat, H., Wu, A. H., Ursin, G., Torkelson, C. J., Wang, R., Yu, M. C., Yee, D., Kurzer, M. S., & Yuan, J. (2019) · Journal of Nutrition · doi:10.1093/jn/nxy316 · Cited by 33 · see citing works

Green tea extract-induced lethal toxicity in fasted but not in nonfasted dogs

Wu, K.-M., Yao, J., & Boring, D. (2011) · International Journal of Toxicology · doi:10.1177/1091581810387445 · Cited by 29 · see citing works

Early Preclinical Changes in Hippocampal CREB-Binding Protein Expression in a Mouse Model of Familial Alzheimer’s Disease

Ettcheto, M., Abad, S., Petrov, D., Pedrós, I., Busquets, O., Sánchez‐López, E., Casadesús, G., Beas‐Zárate, C., Carro, E., Auladell, C., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0690-4 · Cited by 28 · see citing works

Reprint: Good Laboratory Practice: Preventing Introduction of Bias at the Bench

Macleod, M. R., Fisher, M., O’Collins, V. E., et al. (2009) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2009.31 · Cited by 6 · see citing works

Abstract PR-05: Effects of presurgical administration of tea polyphenols in women with operable breast cancer

Campbell, J. L., Cardelli, J. A., McLarty, J. W., et al. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.prev-10-pr-05 · Cited by 5 · see citing works

Reprint: Good laboratory practice: preventing introduction of bias at the bench (vol 29, pg 221, 2009)

Macleod, M. R., Fisher, M., O’Collins, V. E., et al. (2009) · Journal of Cerebral Blood Flow & Metabolism · Cited by 1 · see citing works

Polyphenols and neuroprotection: therapeutic implications for cognitive decline

Caruso, G., Torrisi, S. A., Mogavero, M. P., Currenti, W., Castellano, S., Godos, J., Ferri, R., Galvano, F., Leggio, G. M., Grosso, G., et al. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.108013 · Cited by 140 · see citing works

Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes

Piccialli, I., Tedeschi, V., Caputo, L., D’Errico, S., Ciccone, R., De Feo, V., Secondo, A., & Pannaccione, A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.876614 · Cited by 73 · see citing works

[Eradication of H.pylori may cause gastroesophageal reflux disease: a meta-analysis].

Xie, T., Zheng, H., & Jiang, B. (2013) · PubMed

Epstein-Barr virus infection and oral squamous cell carcinoma risk: A meta-analysis

She, Y., Nong, X., Zhang, M., & Wang, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186860 · Cited by 88 · see citing works

Metformin and reduced risk of hepatocellular carcinoma in diabetic patients: a meta-analysis

Zhang, H., Gao, C., Fang, L., Zhao, H.-C., & Yao, S. (2012) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2012.719926 · Cited by 147 · see citing works

Association between RUNX3 promoter methylation and non-small cell lung cancer: a meta-analysis.

Liang, Y., He, L., Yuan, H., et al. (2014) · PubMed · doi:10.3978/j.issn.2072-1439.2014.04.09 · Cited by 8 · see citing works

Roles of Tregs in development of hepatocellular carcinoma: A meta-analysis

Zhao, H. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i24.7971 · Cited by 64 · see citing works